Last reviewed · How we verify

NCT03312881

Neuropathic Pain in Children: Multimodal Assessment and Diagnosis

Completed Last updated 2 February 2022
What this trial tests

trial testing quantitative sensory testing in Neuropathic Pain in 160 participants. Completed in 31 December 2021.

Timeline
1 September 2017
Primary endpoint
31 July 2021
31 December 2021

Quick facts

Lead sponsorInstitute of Child Health
StatusCompleted
Study typeOBSERVATIONAL
Enrollment160
Start date1 September 2017
Primary completion31 July 2021
Estimated completion31 December 2021
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Institute of Child Health

Who can join

Adults 10 to 18, any sex, with Neuropathic Pain or Child, Only. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Some children experience chronic pain that is related to damage or diseases that affect the nerves that send pain signals. This is known as neuropathic pain. This is not well understood and can be difficult to diagnose. It can often produce unusual feelings such as sensitivity of the skin to light touch. Neuropathic pain is often severe and difficult to treat, and can affect quality of life for the child and family. This study aims to better characterise the symptoms and signs, and impact of neuropathic pain in children.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The feasibility and acceptability of research magnetic resonance imaging in adolescents with moderate-severe neuropathic pain.
    Verriotis M, Moayedi M, Sorger C, Peters J, et al · · 2020 · cited 8× · PMID 32072101 · DOI 10.1097/pr9.0000000000000807
  2. Developmental mechanisms of CPSP: Clinical observations and translational laboratory evaluations.
    Walker SM. · · 2022 · cited 7× · PMID 35910395 · DOI 10.1080/24740527.2021.1999796
  3. Sensitivity and Specificity of a Neuropathic Screening Tool (Self-Report Leeds Assessment of Neuropathic Symptoms and Signs, S-LANSS) in Adolescents With Moderate-Severe Chronic Pain.
    Walker SM, Peters J, Verriotis M, Farag F, et al · · 2024 · cited 4× · PMID 37741521 · DOI 10.1016/j.jpain.2023.09.006
  4. Amygdalar Functional Connectivity Differences Associated With Reduced Pain Intensity in Pediatric Peripheral Neuropathic Pain.
    Verriotis M, Sorger C, Peters J, Ayoub LJ, et al · · 2022 · cited 4× · PMID 35692562 · DOI 10.3389/fpain.2022.918766

Verify or expand the search:

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

Other Institute of Child Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03312881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing